Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Combinations with Radiotherapy in Esophageal Squamous Cell Carcinoma
NCT02459457Phase 3Completed
- Sponsor
- Fudan University
- Start
- Jul 2015
- Primary completion
- Jul 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, cisplatin, carboplatin, fluorouracil in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Fudan University. Started Jul 2015; status: completed.
02
Drugs
paclitaxelcisplatincarboplatinfluorouracil
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT02459457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02459457.